Prognosys Biosciences

Prognosys Biosciences is commercializing haplolnsufficiency profiling, a technology for functionally screening drug compounds in yeast.

History:

Prognosys Biosciences was founded by Mark Chee in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Southern California

Research Focus:
Assay Genomics

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: